ArticlePDF Available

Genetic analyses identify brain imaging-derived phenotypes associated with the risk of intracerebral hemorrhage

Authors:

Abstract

Previous observational studies have reported associations between brain imaging-derived phenotypes (IDPs) and intracerebral hemorrhage (ICH), but the causality between them remains uncertain. We aimed to investigate the potential causal relationship between IDPs and ICH by a two-sample Mendelian randomization (MR) study. We selected genetic instruments for 363 IDPs from a genome-wide association study (GWASs) based on the UK Biobank (n = 33,224). Summary-level data on ICH was derived from a European-descent GWAS with 1,545 cases and 1,481 controls. Inverse variance weighted MR method was applied in the main analysis to investigate the associations between IDPs and ICH. Reverse MR analyses were performed for significant IDPs to examine the reverse causation for the identified associations. Among the 363 IDPs, isotropic or free water volume fraction (ISOVF) in the anterior limb of the left internal capsule was identified to be associated with the risk of ICH (OR per 1-SD increase, 4.62 [95% CI, 2.18–9.81], P = 6.63 × 10−5). In addition, the reverse MR analysis indicated that ICH had no effect on ISOVF in the anterior limb of the left internal capsule (beta, 0.010 [95% CI, −0.010-0.030], P = 0.33). MR-Egger regression analysis showed no directional pleiotropy for the association between ISOVF and ICH, and sensitivity analyses with different MR models further confirmed these findings. ISOVF in the anterior limb of the left internal capsule might be a potential causal mediator of ICH, which may provide predictive guidance for the prevention of ICH. Further studies are warranted to replicate our findings and clarify the underlying mechanisms.
Received: November 8, 2023. Revised: December 8, 2023. Accepted: December 9, 2023
© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Cerebral Cortex, 2024, 1–8
https://doi.org/10.1093/cercor/bhad518
Original Article
Genetic analyses identify brain imaging-derived
phenotypes associated with the risk of intracerebral
hemorrhage
Yi Liu1,, Yiming Jia1,,Hongyan Sun2,Lulu Sun1,Yinan Wang1, Qingyun Xu1,Yu He1,Xinyue Chang1, Daoxia Guo3,Mengyao Shi1,
Guo-Chong Chen4,Jin Zheng5,*, Zhengbao Zhu1,*
1Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory
of Geriatric Diseases and Immunology, 199 Renai Road, Industrial Park District, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China,
2Department of Medical Imaging, 11 Guangqian Road, Xiangcheng District, The Aff iliated Guangji Hospital of Soochow University, Suzhou, China,
3School of Nursing, 333 Ganjiang East Road, Gusu District, Suzhou Medical College of Soochow University, Suzhou, China,
4Department of Nutrition and Food Hygiene, School of Public Health,199 Renai Road, Industrial Park District, Suzhou Medical College of Soochow University,
Suzhou, China,
5Department of Neurology, Minhang Hospital, 170 Xinsong Road, Xinzhuang Town, Minhang District, Fudan University, Shanghai, China
*Corresponding authors: Zhengbao Zhu, Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational
Medicine for Geriatric Diseases, Suzhou Medical College of Soochow University, 199 Renai Road, Industrial Park District, Suzhou, Jiangsu Province 215123, China.
Email: zbzhu@suda.edu.cn; Jin Zheng, Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China. Email: Zhengjin22163@fudan.edu.cn
Yi Liu and Yiming Jia contributed equally to this work.
Previous observational studies have reported associations between brain imaging-derived phenotypes (IDPs) and intracerebral hem-
orrhage (ICH), but the causality between them remains uncertain. We aimed to investigate the potential causal relationship between
IDPs and ICH by a two-sample Mendelian randomization (MR) study.We selected genetic instruments for 363 IDPs from a genome-wide
association study (GWASs) based on the UK Biobank (n=33,224). Summary-level data on ICH was derived from a European-descent
GWAS with 1,545 cases and 1,481 controls. Inverse variance weighted MR method was applied in the main analysis to investigate the
associations between IDPs and ICH. Reverse MR analyses were performed for significant IDPs to examine the reverse causation for the
identified associations. Among the 363 IDPs, isotropic or free water volume fraction (ISOVF) in the anterior limb of the left internal
capsule was identified to be associated with the risk of ICH (OR per 1-SD increase, 4.62 [95% CI, 2.18–9.81], P=6.63 ×105). In addition,
the reverse MR analysis indicated that ICH had no effect on ISOVF in the anterior limb of the left internal capsule (beta, 0.010 [95% CI,
0.010-0.030], P=0.33). MR-Egger regression analysis showed no directional pleiotropy for the association between ISOVF and ICH, and
sensitivity analyses with different MR models further confirmed these findings. ISOVF in the anterior limb of the left internal capsule
might be a potential causal mediator of ICH, which may provide predictive guidance for the prevention of ICH. Further studies are
warranted to replicate our findings and clarify the underlying mechanisms.
Key words:brain imaging-derived phenotypes; stroke; intracerebral hemorrhage; biomarker; Mendelian randomization.
Introduction
Stroke is the second leading cause of death and the major cause
of long-term disability worldwide (Herpich and Rincon 2020), and
intracerebral hemorrhage (ICH) accounts for about 10% to 20% of
all stroke (An et al. 2017). In 2018, the incidence of ICH was 24.6
per 100,000 person-years, and the number of the patients with
ICH was expected to increase continually (Ziai and Carhuapoma
2018). Identification of novel markers is highly desirable for bet-
ter refining risk prediction and understanding the pathogenesis
of ICH.
Mounting evidence had suggested critical roles of brain
imaging-derived phenotypes (IDPs) in the diagnosis and treat-
ment of ICH. For instance, it has been shown that diffusion-
weighted imaging-hyperintensities in the cortex and subcortical
white matter was associated with a high predisposition to the
development of ICH (Kimberly et al. 2009). In terms of the
prognostic value, the presence of spot sign on magnetic resonance
imaging (MRI) was reported as an independent biomarker of
hematoma expansion and poor functional outcome for patients
with acute ICH (Valyraki et al. 2023). Similarly, noncontrast com-
puted tomography hypodensities could also provide additional
information for the risk stratification of hematoma expansion
after ICH (Morotti et al. 2023). Of note, the aforementioned
associations were obtained from observational studies, while
confounding and reverse-causality biases were difficult to avoid
in these studies (Lawlor et al. 2008). Recently, Nelson et al. (2015)
indicated that genomics had the potential to elucidate the causal
pathways linking phenotypes and diseases. Fortunately, recent
advancement in high-throughput genotyping and neuroimaging
techniques enabled genome-wide association study (GWAS) to
comprehensively reveal genetic determinants of IDPs (Smith et al.
2021). Such developments offered an opportunity to explore the
potential causal relationships between IDPs and ICH through
Mendelian randomization (MR) design.
MR is an emerging genetic epidemiological method using sin-
gle nucleotide polymorphisms (SNPs) related to the exposure as
instrumental variables to estimate the associations between the
exposures and the diseases of interest (Smith and Ebrahim 2003;
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
2|Cerebral Cortex, 2024
Sanderson et al. 2022). Given that genetic variants are randomly
allocated during conception, residual confounding and reverse
causation biases could be minimized in MR studies (Davies et al.
2018). MR design has been previously applied to investigate the
associations between several modifiable factors and the risk of
ICH, including blood pressure (Georgakis et al. 2020), lipids (Yu
et al. 2022), vitamin D (Szejko et al. 2022), etc. However, the
potential causal associations of IDPs with ICH have not been
assessed via MR design. Herein, we conducted a two-sample MR
study to estimate the associations between 363 IDPs and ICH.
Methods
Study design
We aimed to identify brain-imaging predictors for ICH from the
genetic perspective in this two-sample MR study (Fig. 1). MR
studies are based on three main assumptions: (i) the genetic
instruments must be associated with the exposure; (ii) the
genetic instruments must be independent of confounders; and
(iii) and the genetic instruments must influence the outcome
only through the exposure. Summary-level data of IDPs and ICH
utilized in the present study were derived from publicly available
GWASs of European ancestry (Woo et al. 2014;Smith et al.
2021). The participant selection, participants’ characteristics, and
genotyping were described in detail in previous studies (Woo et al .
2014;Smith et al. 2021). The protocol and data collection were
approved by the ethics committee of the original GWASs, and
written informed consent was obtained from each participant
before data collection.
Data source and sample overlap
We obtained the summary statistics for 587 brain structural IDPs
(Guo et al. 2022) based on the GWAS dataset released by Smith
et al. (2021), involving 33,224 European individuals from the UK
Biobank (Supplementary Table 1). The neuroimaging measures
and processing methods were described in detail in the online
reference of UK Biobank (https://biobank.ctsu.ox.ac.uk/crystal/
crystal/docs/brain_mri.pdf). Summary statistics for ICH were
obtained from the International Stroke Genetics consortium’s
GWAS meta-analysis of six European-descent cohorts, including
1,545 cases and 1,481 controls. ICH cases were defined as
new and acute (<24 h) neurological deficits with presence of
intraparenchymal bleeding according to brain imaging.
Given that the potential overlap between participants in expo-
sure and outcome GWASs may lead to weak instrument bias
(Burgess et al. 2016), we assessed the bias from sample overlap
and the corresponding type I error rate through an online web
tool (https://sb452.shinyapps.io/overlap/)(Burgess et al. 2016).
Instrument selection
In this study, SNPs that had been identified to be associated with
IDPs at the genome-wide significance level (Pvalue <5×108)
and not in linkage disequilibrium (LD) with other SNPs (r2<0.1
within a clumping window of 500 kb) were selected as instru-
mental variables to proxy these IDPs. When we encountered
certain SNPs exhibiting LD above a threshold of r2= 0.1, only
the SNP with the lowest Pvalue for association with the IDP
was selected. Palindromic SNPs were excluded during the har-
monization process. We calculated the phenotypic variance of
each IDP explained by the corresponding instruments using the
package gtx in the statistical software R, and the calculation
formula had been previously described in detail (Dastani et al.
2012). To ensure the reliability of causal inference, we removed
the IDPs whose phenotypic variance explained by genetic variants
was <0.5% to reach a sufficient statistical power (Chong et al.
2019). Furthermore, we excluded the IDPs associated with less
than three SNPs to meet the minimum requirement of num-
ber of SNPs for some sensitivity analyses (Hemani et al. 2018)
(Supplementary Fig. 1).
According to the above exclusion criteria, 224 of the 587 IDPs
were ruled out. Finally, a total of 363 IDPs were retained for MR
analyses (Fig. 1). Overview of the SNPs used as genetic instru-
ments was listed in Supplementary Table 2.Wecalculatedthe
F-statistic to evaluate the strength of the genetic instruments
for IDPs. The F-statistic is an indicator of the extent (size and
probability) of the relative bias that is likely to occur in estimating
a causal relationship using the instrumental variables (Stock
et al. 2002), and the F-statistic greater than 10 suggests a strong
instrument (Brion et al. 2013).
Statistical analysis
In the main analysis, we adopted the inverse-variance weighted
(IVW) method to estimate the associations between 363 IDPs and
the risk of ICH (Lawlor et al. 2008). Heterogeneity among the
included SNPs was evaluated by Cochran’s Q statistic (Bowden
et al. 2016). A random-effect IVW model was used if the hetero-
geneity existed; otherwise, a fixed-effect IVW model was used. We
leveraged the online web tool (https://shiny.cnsgenomics.com/
mRnd/) to estimate the power for the MR analyses (Brion et al.
2013).
Given that IVW estimates were imprecise in the presence of
invalid instruments or pleiotropy, we further performed sensitiv-
ity analyses with the following MR methods to assess the robust-
ness of our findings: the penalized IVW method could penalize
the SNPs with pleiotropy (Xu et al. 2022); the maximum likelihood
method enabled us to make a valid estimation in the case of
measurement error in SNP-exposure association (Hemani et al.
2018); the MR pleiotropy residual sum and outlier (MR-PRESSO)
method was capable of identifying outlying SNPs and providing
reliable estimates with outlier correction (Ong and Macgregor
2019); the MR robust adjusted profile score (MR-RAPS) method
was robust to the violations of key MR assumption (Zhao et al.
2020); the leave-one-out method was utilized to test whether the
studied associations were driven by an individual SNP through
sequentially dropping each of them (Hemani et al. 2018); and
the MR-Egger regression was effective in reflecting the potential
pleiotropy by its intercept term (Hemani et al. 2018).
For IDPs identified to be associated with ICH, we further per-
formed MR analyses with ICH as the exposure and these IDPs
as the outcomes to determine the reverse causation between
significant IDPs and ICH. The instrument selection for ICH in the
reverse MR analyses followed the same criteria as that for IDPs
in the forward MR analyses. Reverse MR analyses used the same
analytical models as that in forward MR analyses.
In the forward MR analyses,the results for ICH are presented as
odds ratios (ORs) with their 95% confidence intervals (CIs), and a
2-sided P<1.38 ×104(Bonferroni-corrected significance thresh-
old calculated as 0.05/363) was considered statistically significant.
In the reverse MR analyses, the results for IDPs were presented as
betas with their 95% CIs, and a 2-sided P<0.05 was considered as
suggestive evidence for potential reverse causation. In addition,a
2-sided P<0.05 was considered as suggestive evidence for poten-
tial pleiotropy in the MR-Egger regression analyses. All analyses
were performed in R (version 3.4.3; R Development Core Team)
with the packages gtx, MendelianRandomization, MRPRESSO, and
TwoSampleMR.
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
Liu et al. |3
Fig. 1. Conceptual workflow of this MR study. Abbreviations: GWAS, genome-wide association study; IDP, imaging-derived phenotype; IVW, inverse-
variance weighted; MR, Mendelian randomization; MR-PRESSO, MR pleiotropy residual sum and outlier; MR-RAPS, MR robust adjusted profile score;
SNP, single nucleotide polymorphism.
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
4|Cerebral Cortex, 2024
Fig. 2. Circular Manhattan plot for the inverse-variance weighted MR estimates of the associations between IDPs and the intracerebral hemorrhage. The
black dashed line indicates the Bonferroni-corrected significance threshold (P<1.38 ×104), and the significant imaging-derived phenotype (IDP) were
annotated with labels. The deep color bar represents the significant IDP in MR analyses. According to the tissue/region listed in Supplementary Table 1,
we grouped the 363 IDPs. The detailed results are available in Supplementary Table 5. Abbreviation: ISOVF, isotropic or free water volume fraction.
Results
Strength of the genetic instruments for IDPs
A total of 363 IDPs were analyzed in this study (Fig. 1), and
the detailed information about genetic instruments for IDPs was
presented in Supplementary Table 2. The phenotypic variance
of IDPs explained by the genetic instruments ranged from 0.5%
for fractional anisotropy (FA) in the right medial lemniscus to
7.50% for intracellular volume fraction in the left inferior fronto-
occipital fasciculus (Supplementary Table 2). The F-statistics for
the genetic instruments of the IDPs ranged from 24 for FA in the
left medial lemniscus to 155 for the volume of the right post-
central gyrus (Supplementary Table 2), suggesting that there was
no instrument bias in this study. This MR analysis had sufficient
power to detect small effect sizes (e.g. OR = 1.2) for the majority of
the IDPs (Supplementary Table 3). The characteristics of GWASs
used for instrument selection and outcome were described in
Supplementary Table 4.
Associations between IDPs and ICH
Figure 2 showed the associations between 363 IDPs and the risk
of ICH in the main analysis, and the detailed results were pre-
sented in Supplementary Table 5. Among these IDPs, we found
that genetically determined high isotropic or free water volume
fraction (ISOVF) in the anterior limb of the left internal capsule
was significantly associated with an increased risk of ICH (OR per
1-SD increase, 4.62; 95% CI, 2.18–9.81; P= 6.63 ×105)(Fig. 3). The
characteristic of each genetic variant for ISOVF in the anterior
limb of the left internal capsule was available in Supplementary
Table 6,andSupplementary Fig. 2 illustrated the associations of
each genetic variant for ISOVF in the anterior limb of the left
internal capsule with the risk of ICH.
We also performed a series of sensitivity analyses to validate
the findings in the main analysis (Fig. 3). In the penalized IVW
MR analyses to penalize the SNPs with pleiotropy, genetically
determined high ISOVF in the anterior limb of the left internal
capsule was positively associated with the risk of ICH (OR per 1-SD
increase: 4.19; 95% CI: 2.06–8.52; P= 7.49 ×105). In the maximum
likelihood MR analysis, genetically determined high ISOVF in the
anterior limb of the left internal capsule was significantly related
to an increased risk of ICH (OR per 1-SD increase: 4.69; 95%
CI: 2.15–10.19; P= 9.79 ×105). In the MR-PRESSO analyses effec-
tive in identifying pleiotropic outliers, the association between
genetically determined high ISOVF in the anterior limb of the
left internal capsule and the risk of ICH (OR per 1-SD increase:
4.19; 95% CI: 1.95–9.02; P= 2.46 ×104) remained significant. The
MR-RAPS analyses with robustness to the key MR assumptions
showed a significantly positive association between genetically
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
Liu et al. |5
Fig. 3. Association between ISOVF in the anterior limb of the left internal capsule and intracerebral hemorrhage in different MR models. (A) Association
between ISOVF in the anterior limb of the left internal capsule and intracerebral hemorrhage in forward MR analyses. Odds ratios (ORs) and confidence
intervals (CIs) of intracerebral hemorrhage are revealed per 1-SD change in mean ISOVF in the anterior limb of the left internal capsule. The pattern
diagram indicates internal capsule. (B) Association between ISOVF in the anterior limb of the left internal capsule and intracerebral hemorrhage in
reverse MR analyses. Estimates and confidence intervals (CIs) reveal change in mean ISOVF in the anterior limb of the left internal capsule associated
with intracerebral hemorrhage. The pattern diagram indicates internal capsule. Abbreviations: IDP, imaging-derived phenotype; ISOVF, isotropicorfree
water volume fraction; IVW, inverse-variance weighted; MR, Mendelian randomization; MR-RAPS, MR robust adjusted profile score; MR-PRESSO, MR
pleiotropy residual sum and outlier; SNP, single nucleotide polymorphism.
determined high ISOVF in the anterior limb of the left internal
capsule and the risk of ICH (OR per 1-SD increase: 4.25; 95%
CI: 2.00–9.04; P= 1.70 ×104). Leave-one-out analyses indicated
that no individual SNP substantially drove these associations
(Supplementary Fig. 2), and the intercept terms of the MR-Egger
regression showed no potential pleiotropy for these associations
(all P>0.05) (Supplementary Table 7).
Reverse MR analyses
Reverse MR analyses were performed to evaluate the potential
causal effect of ICH on ISOVF in the anterior limb of the left
internal capsule. The IVW MR analysis suggested that genetically
determined ICH was not associated with ISOVF in the anterior
limb of the left internal capsule (beta, 0.010; 95% CI, 0.010–0.030;
P= 0.33) (Fig. 3). The characteristic of each genetic variant for ICH
was available in Supplementary Table 8 and Supplementary Fig. 3
illustrated the associations of each genetic variant for ICH with
ISOVF in the anterior limb of the left internal capsule.
The penalized IVW MR analysis (beta: 0.001; 95% CI: 0.020–
0.020; P= 0.91), the maximum likelihood MR analysis (beta:
0.010; 95% CI: 0.010–0.030; P= 0.32), the MR-PRESSO analysis
(beta: 0.002; 95% CI: 0.004–0.001; P= 0.88), and the MR-
RAPS analysis (beta: 0.002; 95% CI: 0.030–0.020; P= 0.84) also
indicated that genetically determined ICH was not associated
with ISOVF in the anterior limb of the left internal capsule (Fig. 3).
Furthermore, leave-one-out analyses indicated that no individual
SNP substantially drove these associations (Supplementary
Fig. 3), and the intercept terms of the MR-Egger regression
showed no potential pleiotropy for these associations (all P>0.05)
(Supplementary Table 7).
Moreover, our findings based on a two-sample MR framework
were hardly influenced by the bias from sample overlap (bias
<0.2, regardless of overlap proportion) (Supplementary Table 9).
Discussion
To our knowledge, this is the first MR study to assess the potential
causal relationship between IDPs and ICH. Among the 363 IDPs,
genetically determined ISOVF in the anterior limb of the left
internal capsule was identified to be positively associated with the
risk of ICH, while no significant association was observed between
genetically predicted ICH and ISOVF in the anterior limb of the left
internal capsule. Sensitivity analyses with different MR models
robustly confirmed these associations. Our findings suggested
that ISOVF in the anterior limb of the left internal capsule might
be a valuable imaging predictor for incident ICH.
Internal capsule is a compact white matter bundle processing
sensory, motor, and visual information (Li et al. 2021). Pathological
changes in the internal capsule have been known to result in
severe sensorimotor deficits in human ICH (Hijioka et al. 2016).
In a prospective cohort study of ICH patients, the internal capsule
was one of the most common predisposing sites for ICH and this
site of bleeding had an influence on the mortality (Smajlovi´
cetal.
2008). Another population-based study also indicated that hem-
orrhagic location on computed tomography scans had prognostic
value for patients with ICH (Eslami et al. 2019). Moreover, it has
been reported that expansion of hematoma into the internal cap-
sule was a critical determinant of the ICH mortality rate and the
severity of neurological dysfunctions after ICH (Matsushita et al.
2013). These findings suggested that the imaging characteristics
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
6|Cerebral Cortex, 2024
of internal capsule had the potential to indicate the development
of ICH.
Our study extended this information to the occurrence of ICH,
and demonstrated the important role of internal capsule in the
prediction of ICH. As a fiber tract located between the caudate and
lentiform nuclei (Zhou et al. 2003), the anterior limb of the internal
capsule is responsible for the connection of the thalamic nuclei,
prefrontal cortex, and cingulate gyrus (Thau et al. 2022). ISOVF is
a neurite orientation dispersion and density imaging metric that
can functionally complement diffusion tensor imaging metrics
to detect microstructural changes in white matter (Bagdasarian
et al. 2021). In the present study, we found that high ISOVF in the
anterior limb of the left internal capsule was associated with an
increased risk of ICH, and no reverse association was observed
for them. This is a strictly one-sided relationship that does not
apply to the ISOVF in the anterior limb of the right internal
capsule. Axer et al. (1999) analyzed slices of eight human brain
hemispheres by confocal laser and polarized light microscopy,
and found that the anterior limb of the left internal capsule
had more and smaller fiber tracts than the anterior limb of the
right internal capsule. Similarly, Peled et al. (1998) investigated the
fiber orientation in the internal capsule of 24 healthy volunteers
using MRI and observed that the left internal capsule was more
likely to have fibers crossing or fanning out from the direction of
the main tract than the right internal capsule. Therefore, more
fiber bundles on the anterior limb of the left internal capsule
may be an underlying explanation for this strictly one-sided
relationship. Nevertheless, further studies are warranted to verify
our findings and explore exact mechanisms. Our findings sug-
gested that ISOVF in the anterior limb of the left internal capsule
might be a potential imaging biomarker for the risk prediction
of ICH.
The mechanisms underlying the association between ISOVF in
the anterior limb of the left internal capsule and ICH were not
well defined, although several biological mechanisms have been
suggested. As a predilection site of ICH, basal ganglia contains
plenty of bundles of white matter fiber, while the cerebrospinal
tract in the internal capsule is the main component of these
fiber bundles. Such nerve fibers are vulnerable to the direct
injury due to hematoma compression and pave the way to the
secondary neurological deterioration (Jiang et al. 2019). MRI-based
extracellular free water modeling was known to be sensitive
to neuroinflammation, so ISOVF could be deemed as a brain-
imaging marker of neuroinflammatory response (Andica et al.
2022). It had been reported that the internal capsule was a com-
pact white matter bundle (Li et al. 2021) and ISOVF was effective in
detecting microstructural changes in white matter (Bagdasarian
et al. 2021). Therefore, white matter lesions might be a biologi-
cal rationale underlying the identified association. White matter
hyperintensity is a well-known imaging marker of small vessel
disease damage (Wilson et al. 2014). Several studies had revealed
a relationship between leukoaraiosis and ICH (Smith et al. 2002;
Smith et al. 2004;Neumann-Haefelin et al. 2006;Palumbo et al.
2007). In a prospective cohort study, white matter lesions were
reported as radiological indicators of underlying vasculopathy for
ICH patients without antithrombotic therapy (Smith et al. 2004).
In addition, the amount of hemorrhages and white matter lesions
were both found to be able to indicate the likelihood of a future
vascular rupture (Smith et al. 2004). Collectively, white matter
lesions might be helpful to interpret the identified association.
Previous experimental evidence has supported the etiologic roles
of edema and the mass effect of the hematoma in hemorrhagic
brain damage in internal capsule lesioned model rats, indicating
that accumulated extracellular free water and increased ISOVF in
the internal capsule were potential contributors to the patholo-
gies of ICH (Masuda et al. 2007).
Our study has important clinical and public health implica-
tions in better understanding the etiologic associations between
IDPs and ICH, and further providing new insights in the man-
agement of ICH. Based on our findings, measuring ISOVF in the
anterior limb of the left internal capsule may provide useful
information to identify and monitor high-risk individuals for
ICH, and those with high ISOVF in the anterior limb of the left
internal capsule should receive early intervention with optimal
adjunctive medical therapy to reduce the risk of ICH. Further
studies are needed to confirm our findings and assess the cost-
effectiveness of detecting ISOVF in the anterior limb of the left
internal capsule in the prevention of ICH. In addition, our findings
are preliminary hints and worth further exploring the potential
mechanisms. It is of clinical interest to assess the predictive value
of ISOVF in the anterior limb of the left internal capsule and ICH
in a clinical setting before making assumptions about preventive
strategies.
The present study has several strengths. Firstly, this is the first
MR study to evaluate the potential causal associations between
363 IDPs and ICH using the genomics and neuroimaging data.
Secondly, this study was based on large-scale GWASs and multiple
analytical models, which enabled us to make a reliable causal
inference with a high statistical power. Some limitations should
also be discussed here. Firstly, it is difficult to completely exclude
biases from invalid instruments and pleiotropy in the MR study.
However, in the present study, sensitivity analyses with different
MR models yielded similar results as the main analyses, and the
MR-PRESSO method and the MR-Egger regression suggested no
pleiotropy for the identified association. Therefore, the influence
of invalid instrument and pleiotropy on our findings was min-
imal. Secondly, participant overlap between the exposure and
outcome GWASs may introduce weak instrument bias. Further MR
studies based on the independent cohorts without overlapping
participants are needed to deeper investigate the relationship
between IDPs and ICH. Thirdly, MR estimate represents the risk-
modifying effect of the lifetime exposure to a certain factor,
so the results should not be directly interpreted as the associ-
ations of short-term alterations in imaging features with ICH.
Finally, all the participants included in our study were of European
descent, which lowered the population stratification bias but lim-
ited the generalizability of the findings. Further studies conducted
among non-European populations are needed to confirm our
findings.
Conclusion
In conclusion, in this two-sample MR study, we identified ISOVF
in the anterior limb of the left internal capsule as the potential
causal mediator of ICH. Further studies are needed validate our
findings and determine the potential mechanisms.
Acknowledgments
We thank the investigators of UK Biobank, International Stroke
Genetics consortium, and the European-descent GWASs of brain
imaging-derived phenotypes and intracerebral hemorrhage for
making their results publicly available. Full acknowledgement
and funding statements for each of these resources are available
via the relevant cited reports.
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
Liu et al. |7
Author contributions
Yi Liu (Conceptualization, Data curation, Formal analysis, Fund-
ing acquisition, Writing—original draft), Yiming Jia (Conceptu-
alization, Data curation, Formal analysis, Funding acquisition,
Writing—original draft), Hongyan Sun (Conceptualization, Data
curation), Lulu Sun (Conceptualization, Data curation, Formal
analysis), Yinan Wang (Data curation, Formal analysis, Investiga-
tion), Qingyun Xu (Data curation, Formal analysis), Yu He (Formal
analysis, Resources), Xinyue Chang (Data curation, Investigation),
Daoxia Guo (Investigation, Methodology), Mengyao Shi (Inves-
tigation, Methodology), Guo-Chong Chen (Funding acquisition,
Investigation, Methodology), Jin Zheng (Data curation, Funding
acquisition, Investigation, Resources), and Zhengbao Zhu (Con-
ceptualization, Data curation, Formal analysis, Funding acquisi-
tion, Investigation, Methodology).
Supplementary material
Supplementary material is available at Cerebral Cortex online.
Funding
National Natural Science Foundation of China (grant: 82103917),
the Suzhou Science and Technology Project (grant: SKY2023132),
and the Natural Science Foundation of Jiangsu Province (grant:
BK20210716).
Conflict of interest statement: The authors report no conflict of
interest.
References
An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical fea-
tures of intracerebral hemorrhage: An update. JStroke. 2017:19(1):
3–10.
Andica C, Hagiwara A, Yokoyama K, Kato S, Uchida W, Nishimura
Y, Fujita S, Kamagata K, Hori M, Tomizawa Y, et al.
Multimodal magnetic resonance imaging quantification of
gray matter alterations in relapsing-remitting multiple sclerosis
and neuromyelitis optica spectrum disorder. J Neurosci Res.
2022:100(7):1395–1412.
Axer H, Lippitz BE, Von Keyserlingk DG. Morphological asymmetry
in anterior limb of human internal capsule revealed by confocal
laser and polarized light microscopy. Psychiatry Res. 1999:91(3):
141–154.
Bagdasarian FA, Yuan X, Athey J, Bunnell BA, Grant SC. NODDI high-
lights recovery mechanisms in white and gray matter in ischemic
stroke following human stem cell treatment. Magn Reson Med.
2021:86(6):3211–3223.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estima-
tion in Mendelian randomization with some invalid instruments
using a weighted median estimator. Genet Epidemiol. 2016:40(4):
304–314.
Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power
in Mendelian randomization studies. Int J Epidemiol. 2013:42(5):
1497–1501.
Burgess S, Davies NM, Thompson SG. Bias due to participant over-
lap in two-sample Mendelian randomization. Genet Epidemiol.
2016:40(7):597–608.
Chong M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, Lali R,
Shoamanesh A, Gerstein HC, Paré G. Novel drug targets for
ischemic stroke identified through Mendelian randomization
analysis of the blood proteome. Circulation. 2019:140(10):819–830.
Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Hen-
neman P, Heid IM, Kizer JR, Lyytikäinen LP, et al. Novel loci for
adiponectin levels and their influence on type 2 diabetes and
metabolic traits: a multi-ethnic meta-analysis of 45,891 individ-
uals. PLoS Genet. 2012:8(3):e1002607.
Davies NM, Holmes MV, Davey Smith G. Reading Mendelian ran-
domisation studies: a guide, glossary, and checklist for clinicians.
BMJ. 2018:362:k601.
Eslami V, Tahsili-Fahadan P, Rivera-Lara L, Gandhi D, Ali H,
Parry-Jones A, Nelson LS, Thompson RE, Nekoobakht-Tak S,
Dlugash R, et al. Inf luence of intracerebral hemorrhage location
on outcomes in patients with severe intraventricular hemor-
rhage. Stroke. 2019:50(7):1688–1695.
Georgakis K, Gill D, Webb AJS, Evangelou E, Elliott P, Sudlow CLM,
Dehghan A, Malik R, Tzoulaki I, Dichgans M. Genetically deter-
mined blood pressure, antihypertensive drug classes, and risk of
stroke subtypes. Neurology. 2020:95(4):e353–e361.
Guo J, Yu K, Dong SS, Yao S, Rong Y, Wu H, Zhang K, Jiang F, Chen YX,
Guo Y, et al. Mendelian randomization analyses support causal
relationships between brain imaging-derived phenotypes and
risk of psychiatric disorders. Nat Neurosci. 2022:25(11):1519–1527.
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D,
Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-base
platform supports systematic causal inference across the human
phenome. elife. 2018:7:e34408.
Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care
Med. 2020:48(11):1654–1663.
Hijioka M, Anan J, Matsushita H, Ishibashi H, Kurauchi Y, Hisatsune
A, Seki T, Katsuki H. Axonal dysfunction in internal capsule is
closely associated with early motor deficits after intracerebral
hemorrhage in mice. Neurosci Res. 2016:106:38–46.
Jiang YB, Wei KY, Zhang XY, Feng H, Hu R. White matter repair and
treatment strategy after intracerebral hemorrhage. CNS Neurosci
Ther. 2019:25(10):1113–1125.
Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith
EE, Greenberg SM. Silent ischemic infarcts are associated with
hemorrhage burden in cerebral amyloid angiopathy. Neurology.
2009:72(14):1230–1235.
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G.
Mendelian randomization: using genes as instruments for mak-
ing causal inferences in epidemiology. Stat Med. 2008:27(8):
1133–1163.
Li J, Xiao L, He D, Luo Y, Sun H. Mechanism of white matter injury
and promising therapeutic strategies of MSCs after intracerebral
Hemorrhage. Front Aging Neurosci. 2021:13:632054.
Masuda T, Hida H, Kanda Y, Aihara N, Ohta K, Yamada K, Nishino
H. Oral administration of metal chelator ameliorates motor dys-
function after a small hemorrhage near the internal capsule in
rat. J Neurosci Res. 2007:85(1):213–222.
Matsushita H, Hijioka M, Hisatsune A, Isohama Y, Iwamoto S,
Terasawa H, Katsuki H. MRI-based analysis of intracerebral hem-
orrhage in mice reveals relationship between hematoma expan-
sion and the severity of symptoms. PLoS One. 2013:8(7):e67691.
Morotti A, Boulouis G, Nawabi J, Li Q , Charidimou A, Pasi M, Schlunk
F, Shoamanesh A, Katsanos AH, Mazzacane F, et al. Using non-
contrast computed tomography to improve prediction of intrac-
erebral Hemorrhage expansion. Stroke. 2023:54(2):567–574.
Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos
A, Sham PC, Li MJ, Wang J, et al. The support of human genetic
evidence for approved drug indications. Nat Genet. 2015:47(8):
856–860.
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
8|Cerebral Cortex, 2024
Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A,
Humpich M, Kastrup A, Kucinski T, Lecei O, Liebeskind DS, et al.
Leukoaraiosis is a risk factor for symptomatic intracerebral hem-
orrhage after thrombolysis for acute stroke. Stroke. 2006:37(10):
2463–2466.
Ong JS, Macgregor S. Implementing MR-PRESSO and GCTA-GSMR for
pleiotropy assessment in Mendelian randomization studies from
a practitioner’s perspective. Genet Epidemiol. 2019:43(6):609–616.
Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM.
Leukoaraiosis and intracerebral hemorrhage after thrombolysis
in acute stroke. Neurology. 2007:68(13):1020–1024.
Peled S, Gudbjartsson H, Westin CF, Kikinis R, Jolesz FA. Magnetic
resonance imaging shows orientation and asymmetry of white
matter fiber tracts. Brain Res. 1998:780(1):27–33.
Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafò
MR, Palmer T, Schooling CM, Wallace C, Zhao Q , et al. Mendelian
randomization. Nat Rev Methods Primers. 2022:2(1):6.
Smajlovi´
c D, Salihovi ´
cD, ´
C. Ibrahimagi´
cO,Sinanovi
´
cO,Vidovi
´
c
M. Analysis of risk factors, localization and 30-day prognosis of
intracerebral hemorrhage. Bosn J Basic Med Sci. 2008:8(2):121–125.
Smith GD, Ebrahim S. ’Mendelian randomization’: can genetic epi-
demiology contribute to understanding environmental determi-
nants of disease? Int J Epidemiol. 2003:32(1):1–22.
Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM.
Leukoaraiosis is associated with warfarin-related hemorrhage
following ischemic stroke. Neurology. 2002:59(2):193–197.
Smith EE, Gurol ME, Eng JA, Engel CR, Nguyen TN, Rosand J,
Greenberg SM. White matter lesions, cognition, and recur-
rent hemorrhage in lobar intracerebral hemorrhage. Neurology.
2004:63(9):1606–1612.
Smith SM, Douaud G, Chen W, Hanayik T, Alfaro-Almagro F, Sharp K,
Elliott LT. An expanded set of genome-wide association studies of
brain imaging phenotypes in UK biobank. Nat Neurosci. 2021:24(5):
737–745.
Stock JH, Wright JH, Yogo M. A survey of weak instruments and weak
identification in generalized method of moments. J Bus Econ Stat.
2002:20(4):518–529.
Szejko N, Acosta JN, Both CP, Leasure A, Matouk C, Sansing L, Gill
TM, Hongyu Z, Sheth K, Falcone GJ. Genetically-proxied levels of
vitamin D and risk of intracerebral hemorrhage. J Am Heart Assoc.
2022:11(13):e024141.
Thau L, Reddy V, Singh P. Anatomy, Central Nervous Sys-
tem. In: StatPearls. Treasure Island (FL): StatPearls Publishing,
Salah Aboubakr. 2022. https://www.ncbi.nlm.nih.gov/pubmed/
31194336.
Valyraki N, Goujon A, Mateos M, Lecoeuvre A, Lecler A, Raynouard
I, Sabben C, Obadia M, Savatovsky J, Seners P. MRI spot sign
in acute intracerebral hemorrhage: an independent biomarker
of hematoma expansion and poor functional outcome. J Neurol.
2023:270(3):1531–1542.
Wilson D, Charidimou A, Werring DJ. Advances in understand-
ing spontaneous intracerebral hemorrhage: insights from neu-
roimaging. Expert Rev Neurother. 2014:14(6):661–678.
Woo D, Falcone GJ, Devan WJ, Brown WM, Biffi A, Howard TD,
Anderson CD, Brouwers HB, Valant V, Battey TW, et al. Meta-
analysis of genome-wide association studies identifies 1q22 as
a susceptibility locus for intracerebral hemorrhage. Am J Hum
Genet. 2014:94(4):511–521.
Xu S, Wang P, Fung WK, Liu Z. A novel penalized inverse-variance
weighted estimator for Mendelian randomization with applica-
tions to COVID-19 outcomes. Biometrics. 2022:79(3):2184–2195.
Yu Z, Zhang L, Zhang G, Xia K, Yang Q, Huang T, Fan D.
Lipids, Apolipoproteins, statins, and intracerebral Hemorrhage: a
Mendelian randomization study. Ann Neurol. 2022:92(3):390–399.
Zhao QY, Wang JS, Hemani G, Bowden J, Small DS. Statistical
inference in two-sample summary-data Mendelian randomiza-
tion using robust adjusted profile score. Ann Stat. 2020:48(3):
1742–1769.
Zhou SY, Suzuki M, Hagino H, Takahashi T, Kawasaki Y, Nohara S,
Yamashita I, Seto H, Kurachi M. Decreased volume and increased
asymmetry of the anterior limb of the internal capsule in patients
with schizophrenia. Biol Psychiatry. 2003:54(4):427–436.
Ziai WC, Carhuapoma JR. Intracerebral Hemorrhage. Continuum (Min-
neap Minn). 2018:24(6):1603–1622.
Downloaded from https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhad518/7512627 by Suzhou University user on 29 January 2024
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background In acute intracerebral hemorrhage (ICH), the prognostic value of the MRI spot sign on hematoma expansion (HE) and poor functional outcome is poorly known.Methods We retrospectively included patients admitted over a 4-year period for an acute ICH in a single institution using MRI as the first-line imaging tool. The presence and number of MRI spot signs on contrast-enhanced T1-weighted imaging was evaluated by one neuroradiologist, blinded from outcomes. The primary outcome was HE, defined as > 6 mL or > 33% ICH volume growth from initial MRI to 24–48 h follow-up imaging; the secondary outcome was poor 3-month modified Rankin score (4–6).ResultsOverall, 147 patients were included, and 62% had a spot sign. Among the 130 patients with follow-up imaging, 24% experienced HE. HE occurred in 6%, 21% and 43% patients with 0, 1 and ≥ 2 spots, respectively (P < 0.001). The MRI spot sign was independently associated with HE (adjusted OR 6.15 [95% CI 1.60–23.65]; P = 0.008), with a dose-dependent effect. The negative and positive predictive values of the spot sign for HE were 0.94 and 0.35, respectively. Poor functional outcome occurred in 27%, 32% and 71% patients with 0, 1 and ≥ 2 spots, respectively (P < 0.001). In multivariable analysis, the presence of ≥ 2 spots was independently associated with poor functional outcome (adjusted OR 3.67 [95% CI 1.21–11.10]; P = 0.024).Conclusion The MRI spot sign is an independent biomarker of HE, and the presence of ≥ 2 spots is independently associated with poor 3-month outcome. The lack of spot sign is highly predictive of a favorable evolution.
Article
Full-text available
Observational studies have reported the correlations between brain imaging-derived phenotypes (IDPs) and psychiatric disorders; however, whether the relationships are causal is uncertain. We conducted bidirectional two-sample Mendelian randomization (MR) analyses to explore the causalities between 587 reliable IDPs (N = 33,224 individuals) and 10 psychiatric disorders (N = 9,725 to 161,405). We identified nine IDPs for which there was evidence of a causal influence on risk of schizophrenia, anorexia nervosa and bipolar disorder. For example, 1 s.d. increase in the orientation dispersion index of the forceps major was associated with 32% lower odds of schizophrenia risk. Reverse MR indicated that only genetically predicted schizophrenia was positively associated with two IDPs, the cortical surface area and the volume of the right pars orbitalis. We established the BrainMR database (http://www.bigc.online/BrainMR/) to share our results. Our findings provide potential strategies for the prediction and intervention for psychiatric disorder risk at the brain-imaging level.
Article
Full-text available
Background The evidence linking vitamin D (VitD) levels and spontaneous intracerebral hemorrhage (ICH) remains inconclusive. We tested the hypothesis that lower genetically determined VitD levels are associated with higher risk of ICH. Methods and Results We conducted a 2 sample Mendelian Randomization (MR) study using publicly available summary statistics from published genome‐wide association studies of VitD levels (417 580 study participants) and ICH (1545 ICH cases and 1481 matched controls). We used the inverse‐variance weighted approach to generate causal estimates and the MR Pleiotropy Residual Sum and Outlier and MR‐Egger approaches to assess for horizontal pleiotropy. To account for known differences in their underlying mechanism, we implemented stratified analysis based on the location of the hemorrhage within the brain (lobar or nonlobar). Our primary analysis indicated that each SD decrease in genetically instrumented VitD levels was associated with a 60% increased risk of ICH (odds ratio [OR], 1.60; [95% CI, 1.05–2.43]; P =0.029). We found no evidence of horizontal pleiotropy (MR‐Egger intercept and MR Pleiotropy Residual Sum and Outlier global test with P >0.05). Stratified analyses indicated that the association was stronger for nonlobar ICH (OR, 1.87; [95% CI, 1.18–2.97]; P =0.007) compared with lobar ICH (OR, 1.43; [95% CI, 0.86–2.38]; P =0.17). Conclusions Lower levels of genetically proxied VitD levels are associated with higher ICH risk. These results provide evidence for a causal role of VitD metabolism in ICH.
Article
Full-text available
Objective: To investigate the causal role of lipid or apolipoprotein traits in intracerebral hemorrhage (ICH) and determine the effect of lipid-lowering interventions on the disease. Methods: Two-sample Mendelian randomization (MR) analyses were conducted to evaluate the associations of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), apolipoprotein (Apo)B and ApoA1 levels with risks for ICH, and those of LDL-C- (HMGCR, PCSK9, and NPC1L1) and TG-lowering targets (LPL and APOC3) with ICH. Results: Increased levels of ApoB was associated with a decreased risk of overall ICH (OR 0.623, 95% CI 0.413-0.940; p = 0.024) and lobar ICH (OR 0.579, 95% CI 0.342-0.979; p = 0.042). The inverse relationship remained stable in multivariable MR. In addition, elevated TGs showed a causal effect on lobar ICH in multivariable MR (OR 1.600, 95% CI 1.009-2.537; p = 0.046). The LDL-C-reducing genetic variation alleles at or near the HMGCR gene (mimicking the effect of statins) were predicted to increase the overall and deep ICH risk. Additionally, genetic variation at or near the APOC3 gene suggested that genetically reducing the activity of APOC3 (mimicking antisense anti-apoC3 agents) was predicted to decrease lobar ICH. Interpretation: Genetically predicted elevated ApoB may have a protective effect on overall ICH and lobar ICH, whereas elevated TG was associated with a higher risk of lobar ICH conditional on LDL-C and ApoB. MR analysis supports the conclusion that statins may increase the risk of overall and deep ICH independent of their lipid-lowering effect. More specific lipid-lowering targets may end up being the future. ANN NEUROL 2022.
Article
Full-text available
Purpose Diffusion MRI offers insight into ischemic stroke progression in both human and rodent models. However, diffusion MRI to evaluate therapeutic application of mesenchymal stem cells is limited. Robust analytical techniques are required to identify potential physiological changes as a function of cell therapy in stroke. Here, we seek to establish Neurite Orientation Dispersion and Density Imaging (NODDI) as a feasible method in evaluating stroke evolution in response to cell‐based therapeutics. Methods Diffusion MRI data at 21.1T were acquired from 16 male rats. Rats were grouped randomly: naïve (baseline, N = 5), stroke with injections of phosphate buffered saline (N = 6), stroke with injection of 2D human mesenchymal stem cells (hMSC, N = 5). Data were acquired on days 1, 3, 7, and 21 post‐surgery. DTI and NODDI maps were generated, with regions of interest placed in the ischemic hemisphere external capsule and striatum. Diffusion parameters were compared between groups each day, and within groups across hemispheres and longitudinally. Behavioral characterizations were on days 0 (pre‐surgery), 3, 7, 14, and 21. Results The 2D hMSC preserved diffusional restriction in the external capsule compared to saline (day 1: MD, P = .4060; AD, P = .0220). NODDI indicates that hMSC may have preserved intracellular volume fractions (ICVF: day 1, P = .0086; day 3, P = .0021; day 21, P = .0383). Diffusion metrics of hMSC treated animals were comparable to naïve for the external capsule. Conclusions NODDI compliments DTI metrics, enhances interpretation of tissue outcome in ischemic stroke following hMSC application, and may be useful in evaluating or predicting therapeutic response.
Article
Full-text available
UK Biobank is a major prospective epidemiological study, including multimodal brain imaging, genetics and ongoing health outcomes. Previously, we published genome-wide associations of 3,144 brain imaging-derived phenotypes, with a discovery sample of 8,428 individuals. Here we present a new open resource of genome-wide association study summary statistics, using the 2020 data release, almost tripling the discovery sample size. We now include the X chromosome and new classes of imaging-derived phenotypes (subcortical volumes and tissue contrast). Previously, we found 148 replicated clusters of associations between genetic variants and imaging phenotypes; in this study, we found 692, including 12 on the X chromosome. We describe some of the newly found associations, focusing on the X chromosome and autosomal associations involving the new classes of imaging-derived phenotypes. Our novel associations implicate, for example, pathways involved in the rare X-linked STAR (syndactyly, telecanthus and anogenital and renal malformations) syndrome, Alzheimer’s disease and mitochondrial disorders. The Elliott and Smith teams used imaging and genetics data from 40,000 volunteers in the UK Biobank healthcare study, discovering new genetic influences over brain structure and function, which are of relevance to both rare and common diseases.
Article
BACKGROUND Noncontrast computed tomography hypodensities are a validated predictor of hematoma expansion (HE) in intracerebral hemorrhage and a possible alternative to the computed tomography angiography (CTA) spot sign but their added value to available prediction models remains unclear. We investigated whether the inclusion of hypodensities improves prediction of HE and compared their added value over the spot sign. METHODS Retrospective analysis of patients admitted for primary spontaneous intracerebral hemorrhage at the following 8 university hospitals in Boston, US (1994–2015, prospective), Hamilton, Canada (2010–2016, retrospective), Berlin, Germany (2014–2019, retrospective), Chongqing, China (2011–2015, retrospective), Pavia, Italy (2017–2019, prospective), Ferrara, Italy (2010–2019, retrospective), Brescia, Italy (2020–2021, retrospective), and Bologna, Italy (2015–2019, retrospective). Predictors of HE (hematoma growth >6 mL and/or >33% from baseline to follow-up imaging) were explored with logistic regression. We compared the discrimination of a simple prediction model for HE based on 4 predictors (antitplatelet and anticoagulant treatment, baseline intracerebral hemorrhage volume, and onset-to-imaging time) before and after the inclusion of noncontrast computed tomography hypodensities, using receiver operating characteristic curve and De Long test for area under the curve comparison. RESULTS A total of 2465 subjects were included, of whom 664 (26.9%) had HE and 1085 (44.0%) had hypodensities. Hypodensities were independently associated with HE after adjustment for confounders in logistic regression (odds ratio, 3.11 [95% CI, 2.55–3.80]; P <0.001). The inclusion of noncontrast computed tomography hypodensities improved the discrimination of the 4 predictors model (area under the curve, 0.67 [95% CI, 0.64–0.69] versus 0.71 [95% CI, 0.69–0.74]; P =0.025). In the subgroup of patients with a CTA available (n=895, 36.3%), the added value of hypodensities remained statistically significant (area under the curve, 0.68 [95% CI, 0.64–0.73] versus 0.74 [95% CI, 0.70–0.78]; P =0.041) whereas the addition of the CTA spot sign did not provide significant discrimination improvement (area under the curve, 0.74 [95% CI, 0.70–0.78]). CONCLUSIONS Noncontrast computed tomography hypodensities provided a significant added value in the prediction of HE and appear a valuable alternative to the CTA spot sign. Our findings might inform future studies and suggest the possibility to stratify the risk of HE with good discrimination without CTA.
Article
Mendelian randomization (MR) utilizes genetic variants as instrumental variables (IVs) to estimate the causal effect of an exposure variable on an outcome of interest even in the presence of unmeasured confounders. However, the popular inverse‐variance weighted (IVW) estimator could be biased in the presence of weak IVs, a common challenge in MR studies. In this article, we develop a novel penalized inverse‐variance weighted (pIVW) estimator, which adjusts the original IVW estimator to account for the weak IV issue by using a penalization approach to prevent the denominator of the pIVW estimator from being close to zero. Moreover, we adjust the variance estimation of the pIVW estimator to account for the presence of balanced horizontal pleiotropy. We show that the recently proposed debiased IVW (dIVW) estimator is a special case of our proposed pIVW estimator. We further prove that the pIVW estimator has smaller bias and variance than the dIVW estimator under some regularity conditions. We also conduct extensive simulation studies to demonstrate the performance of the proposed pIVW estimator. Furthermore, we apply the pIVW estimator to estimate the causal effects of five obesity‐related exposures on three coronavirus disease 2019 (COVID‐19) outcomes. Notably, we find that hypertensive disease is associated with an increased risk of hospitalized COVID‐19; and peripheral vascular disease and higher body mass index are associated with increased risks of COVID‐19 infection, hospitalized COVID‐19 and critically ill COVID‐19. This article is protected by copyright. All rights reserved
Article
Herein, we combined neurite orientation dispersion and density imaging (NODDI) and synthetic magnetic resonance imaging (SyMRI) to evaluate the spatial distribution and extent of gray matter (GM) microstructural alterations in patients with relapsing-remitting multiple sclerosis (RRMS) and neuromyelitis optica spectrum disorder (NMOSD). The NODDI (neurite density index [NDI], orientation dispersion index [ODI], and isotropic volume fraction [ISOVF]) and SyMRI (myelin volume fraction [MVF]) measures were compared between age- and sex-matched groups of 30 patients with RRMS (6 males and 24 females; mean age, 51.43 ± 8.02 years), 18 patients with anti-aquaporin-4 antibody-positive NMOSD (2 males and 16 females; mean age, 52.67 ± 16.07 years), and 19 healthy controls (6 males and 13 females; mean age, 51.47 ± 9.25 years) using GM-based spatial statistical analysis. Patients with RRMS showed reduced NDI and MVF and increased ODI and ISOVF, predominantly in the limbic and paralimbic regions, when compared with healthy controls, while only increases in ODI and ISOVF were observed when compared with NMOSD. Compared to NDI and MVF, the changes in ODI and ISOVF were observed more widely, including in the cerebellar cortex. These abnormalities were associated with disease progression and disability. In contrast, patients with NMOSD only showed reduced NDI mainly in the cerebellar, limbic, and paralimbic cortices when compared with healthy controls and patients with RRMS. Taken together, our study supports the notion that GM pathologies in RRMS are distinct from those of NMOSD. However, owing to the limitations of the study, the results should be cautiously interpreted.
Article
Mendelian randomization (MR) is a term that applies to the use of genetic variation to address causal questions about how modifiable exposures influence different outcomes. The principles of MR are based on Mendel’s laws of inheritance and instrumental variable estimation methods, which enable the inference of causal effects in the presence of unobserved confounding. In this Primer, we outline the principles of MR, the instrumental variable conditions underlying MR estimation and some of the methods used for estimation. We go on to discuss how the assumptions underlying an MR study can be assessed and describe methods of estimation that are robust to certain violations of these assumptions. We give examples of a range of studies in which MR has been applied, the limitations of current methods of analysis and the outlook for MR in the future. The differences between the assumptions required for MR analysis and other forms of epidemiological studies means that MR can be used as part of a triangulation across multiple sources of evidence for causal inference. Mendelian randomization is a technique for using genetic variation to examine the causal effect of a modifiable exposure on an outcome such as disease status. This Primer by Sanderson et al. explains the concepts of and the conditions required for Mendelian randomization analysis, describes key examples of its application and looks towards applying the technique to growing genomic datasets.